MEDIPOST Co., Ltd. (078160.KQ)

KRW 12000.0

(-11.37%)

Long Term Debt Summary of MEDIPOST Co., Ltd.

  • MEDIPOST Co., Ltd.'s latest annual long term debt in 2023 was 6.99 Billion KRW , up 464.24% from previous year.
  • MEDIPOST Co., Ltd.'s latest quarterly long term debt in 2024 Q2 was 6.99 Billion KRW , down 0.0% from previous quarter.
  • MEDIPOST Co., Ltd. reported annual long term debt of 1.23 Billion KRW in 2022, up 0.85% from previous year.
  • MEDIPOST Co., Ltd. reported annual long term debt of 1.22 Billion KRW in 2021, up 353.94% from previous year.
  • MEDIPOST Co., Ltd. reported quarterly long term debt of 6.99 Billion KRW for 2024 Q1, down 0.0% from previous quarter.
  • MEDIPOST Co., Ltd. reported quarterly long term debt of 1.34 Billion KRW for 2023 Q1, up 8.4% from previous quarter.

Annual Long Term Debt Chart of MEDIPOST Co., Ltd. (2023 - 2016)

Historical Annual Long Term Debt of MEDIPOST Co., Ltd. (2023 - 2016)

Year Long Term Debt Long Term Debt Growth
2023 6.99 Billion KRW 464.24%
2022 1.23 Billion KRW 0.85%
2021 1.22 Billion KRW 353.94%
2020 270.78 Million KRW -98.92%
2019 24.97 Billion KRW 0.0%
2018 - KRW -100.0%
2017 15.59 Billion KRW 0.0%
2016 15.59 Billion KRW 0.0%

Peer Long Term Debt Comparison of MEDIPOST Co., Ltd.

Name Long Term Debt Long Term Debt Difference
HLB Co., Ltd. 17.93 Billion KRW 60.995%
iNtRON Biotechnology, Inc. 258.29 Million KRW -2608.114%
BINEX Co., Ltd. 5.57 Billion KRW -25.394%
Bioneer Corporation 12.5 Billion KRW 44.041%
Anterogen.Co.,Ltd. - KRW -Infinity%
CrystalGenomics, Inc. 29.88 Billion USD 76.597%
Helixmith Co., Ltd 151.68 Million KRW -4511.63%
Chabiotech Co.,Ltd. 95.06 Billion KRW 92.642%
Medy-Tox Inc. 1.22 Billion KRW -470.622%
Peptron, Inc. 4.5 Billion KRW -55.443%
Amicogen, Inc. 70.65 Billion KRW 90.1%
Genexine, Inc. 22.68 Billion KRW 69.16%
HLB Therapeutics Co.,Ltd. 1.84 Billion KRW -280.119%
LegoChem Biosciences, Inc. 528.37 Million KRW -1223.861%
ALTEOGEN Inc. 1.24 Billion KRW -459.926%
PharmaResearch Co., Ltd. 970.71 Million KRW -620.593%
SillaJen, Inc. 8.13 Billion KRW 14.023%
JETEMA, Co., Ltd. 60 Billion KRW 88.342%
OliX Pharmaceuticals,Inc 35.36 Billion KRW 80.219%
Genomictree Inc. 97.51 Million KRW -7073.125%
MedPacto, Inc. 1.68 Billion KRW -314.65%
D&D Pharmatech 5.12 Billion KRW -36.603%
EASY BIO,Inc. 30 Billion KRW 76.684%
GI Innovation, Inc. 2.9 Billion KRW -140.871%